Company / EPS (Basic)
Vaxcyte, Inc. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$5.63
FY2025
5-year range
-$5.63 / -$1.93
FY2021-FY2025
Trend
-48.2%
vs FY2024
Sector context
#186 of 208
Health Care
What the data says
Vaxcyte, Inc.'s eps (basic) of $-5.63 is lower than 89% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 6 years, ranging from $-5.63 in FY2025 to $-1.93 in FY2021.
Based on SEC 10-K filings.
-5.63 in FY2025.
Declined from $-4.14 to $-5.63 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 208This company -$5.63 Sector average -$0.87
▼
-546.7% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 48.2% year-over-year.
- Ranks #186 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.63 | -48.2% |
| FY2024 | -$3.80 | +8.2% |
| FY2023 | -$4.14 | -20.3% |
| FY2022 | -$3.44 | -78.2% |
| FY2021 | -$1.93 | +36.1% |
| FY2020 | -$3.02 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026